APO RESEARCH · REPORT
Pain Management Drugs
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
Product & engineering
Understand the product.
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
Selected research
Industry Research
Pain Management Drugs Industry Research Report 2026
Market perspective
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
Read the full market overview
Report Scope
This report quantifies the global Pain Management Drugs market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pain Management Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pain Management Drugs Market by Company
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Pain Management Drugs Segment by Type
Generic Opioids
Branded Opioids
NSAIDs
Others
Pain Management Drugs Segment by Application
Hospitals
Drugstores
Others
Pain Management Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pain Management Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pain Management Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pain Management Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pain Management Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Generic Opioids
- Branded Opioids
- NSAIDs
- Others
Applications
- Hospitals
- Drugstores
- Others
Companies covered
- GSK
- Pfizer
- Grunenthal
- Sanofi
- Bayer
- AstraZeneca
- Eli Lilly
- Endo
- Merck
- Yunnan Baiyao
- Teikoku Seiyaku
- Teva
- J&J
- Assertio Therapeutics
- Allergan
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pain Management Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Generic Opioids
- 2.2.3 Branded Opioids
- 2.2.4 NSAIDs
- 2.2.5 Others
- 2.3 Pain Management Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospitals
- 2.3.3 Drugstores
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Pain Management Drugs Breakdown Data by Type
- 3.1 Global Pain Management Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Pain Management Drugs Forecasted Market Size by Type (2027-2032)
4 Pain Management Drugs Breakdown Data by Application
- 4.1 Global Pain Management Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Pain Management Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pain Management Drugs Market Perspective (2021-2032)
- 5.2 Global Pain Management Drugs Growth Trends by Region
- 5.2.1 Global Pain Management Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pain Management Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Pain Management Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Pain Management Drugs Market Dynamics
- 5.3.1 Pain Management Drugs Industry Trends
- 5.3.2 Pain Management Drugs Market Drivers
- 5.3.3 Pain Management Drugs Market Challenges
- 5.3.4 Pain Management Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pain Management Drugs Players by Revenue
- 6.1.1 Global Top Pain Management Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Pain Management Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Pain Management Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pain Management Drugs Head Office and Area Served
- 6.4 Global Pain Management Drugs Players, Product Type & Application
- 6.5 Global Pain Management Drugs Manufacturers Established Date
- 6.6 Global Pain Management Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pain Management Drugs Market Size (2021-2032)
- 7.2 North America Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pain Management Drugs Market Size by Country (2021-2026)
- 7.4 North America Pain Management Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pain Management Drugs Market Size (2021-2032)
- 8.2 Europe Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pain Management Drugs Market Size by Country (2021-2026)
- 8.4 Europe Pain Management Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pain Management Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pain Management Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pain Management Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pain Management Drugs Market Size (2021-2032)
- 10.2 South America Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pain Management Drugs Market Size by Country (2021-2026)
- 10.4 South America Pain Management Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pain Management Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Pain Management Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pain Management Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pain Management Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 GSK
- 12.1.1 GSK Company Information
- 12.1.2 GSK Business Overview
- 12.1.3 GSK Revenue in Pain Management Drugs Business (2021-2026)
- 12.1.4 GSK Pain Management Drugs Product Portfolio
- 12.1.5 GSK Recent Developments
- 12.2 Pfizer
- 12.2.1 Pfizer Company Information
- 12.2.2 Pfizer Business Overview
- 12.2.3 Pfizer Revenue in Pain Management Drugs Business (2021-2026)
- 12.2.4 Pfizer Pain Management Drugs Product Portfolio
- 12.2.5 Pfizer Recent Developments
- 12.3 Grunenthal
- 12.3.1 Grunenthal Company Information
- 12.3.2 Grunenthal Business Overview
- 12.3.3 Grunenthal Revenue in Pain Management Drugs Business (2021-2026)
- 12.3.4 Grunenthal Pain Management Drugs Product Portfolio
- 12.3.5 Grunenthal Recent Developments
- 12.4 Sanofi
- 12.4.1 Sanofi Company Information
- 12.4.2 Sanofi Business Overview
- 12.4.3 Sanofi Revenue in Pain Management Drugs Business (2021-2026)
- 12.4.4 Sanofi Pain Management Drugs Product Portfolio
- 12.4.5 Sanofi Recent Developments
- 12.5 Bayer
- 12.5.1 Bayer Company Information
- 12.5.2 Bayer Business Overview
- 12.5.3 Bayer Revenue in Pain Management Drugs Business (2021-2026)
- 12.5.4 Bayer Pain Management Drugs Product Portfolio
- 12.5.5 Bayer Recent Developments
- 12.6 AstraZeneca
- 12.6.1 AstraZeneca Company Information
- 12.6.2 AstraZeneca Business Overview
- 12.6.3 AstraZeneca Revenue in Pain Management Drugs Business (2021-2026)
- 12.6.4 AstraZeneca Pain Management Drugs Product Portfolio
- 12.6.5 AstraZeneca Recent Developments
- 12.7 Eli Lilly
- 12.7.1 Eli Lilly Company Information
- 12.7.2 Eli Lilly Business Overview
- 12.7.3 Eli Lilly Revenue in Pain Management Drugs Business (2021-2026)
- 12.7.4 Eli Lilly Pain Management Drugs Product Portfolio
- 12.7.5 Eli Lilly Recent Developments
- 12.8 Endo
- 12.8.1 Endo Company Information
- 12.8.2 Endo Business Overview
- 12.8.3 Endo Revenue in Pain Management Drugs Business (2021-2026)
- 12.8.4 Endo Pain Management Drugs Product Portfolio
- 12.8.5 Endo Recent Developments
- 12.9 Merck
- 12.9.1 Merck Company Information
- 12.9.2 Merck Business Overview
- 12.9.3 Merck Revenue in Pain Management Drugs Business (2021-2026)
- 12.9.4 Merck Pain Management Drugs Product Portfolio
- 12.9.5 Merck Recent Developments
- 12.10 Yunnan Baiyao
- 12.10.1 Yunnan Baiyao Company Information
- 12.10.2 Yunnan Baiyao Business Overview
- 12.10.3 Yunnan Baiyao Revenue in Pain Management Drugs Business (2021-2026)
- 12.10.4 Yunnan Baiyao Pain Management Drugs Product Portfolio
- 12.10.5 Yunnan Baiyao Recent Developments
- 12.11 Teikoku Seiyaku
- 12.11.1 Teikoku Seiyaku Company Information
- 12.11.2 Teikoku Seiyaku Business Overview
- 12.11.3 Teikoku Seiyaku Revenue in Pain Management Drugs Business (2021-2026)
- 12.11.4 Teikoku Seiyaku Pain Management Drugs Product Portfolio
- 12.11.5 Teikoku Seiyaku Recent Developments
- 12.12 Teva
- 12.12.1 Teva Company Information
- 12.12.2 Teva Business Overview
- 12.12.3 Teva Revenue in Pain Management Drugs Business (2021-2026)
- 12.12.4 Teva Pain Management Drugs Product Portfolio
- 12.12.5 Teva Recent Developments
- 12.13 J&J
- 12.13.1 J&J Company Information
- 12.13.2 J&J Business Overview
- 12.13.3 J&J Revenue in Pain Management Drugs Business (2021-2026)
- 12.13.4 J&J Pain Management Drugs Product Portfolio
- 12.13.5 J&J Recent Developments
- 12.14 Assertio Therapeutics
- 12.14.1 Assertio Therapeutics Company Information
- 12.14.2 Assertio Therapeutics Business Overview
- 12.14.3 Assertio Therapeutics Revenue in Pain Management Drugs Business (2021-2026)
- 12.14.4 Assertio Therapeutics Pain Management Drugs Product Portfolio
- 12.14.5 Assertio Therapeutics Recent Developments
- 12.15 Allergan
- 12.15.1 Allergan Company Information
- 12.15.2 Allergan Business Overview
- 12.15.3 Allergan Revenue in Pain Management Drugs Business (2021-2026)
- 12.15.4 Allergan Pain Management Drugs Product Portfolio
- 12.15.5 Allergan Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst